Iovance Biotherapeutics

IOVA

NASDAQHealth Care

Income Statement

Total Revenue$164.07M

Gross Profit$56.13M

Operating Income$-395.28M

EBITDA$-326.93M

EBIT$-375.01M

Pre-tax Income$-393.05M

Net Income$-372.18M

Cash Equivalent$167.08M

Total Debt$75.81M

Book Value$733.11M

Book Value Per Share2.51

Return on Equity (ROE)-52.39%

Return on Assets (ROA)-40.88%

Return on Invested Capital (ROI)-52.32%

Net Profit Margin-226.84%

Current Ratio3.74

Quick Ratio3.21

Long-Term Debt / Equity0.00